Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti infectives. Galapagos approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target to drug discovery products and services to pharmaceutical and biotech companies.
Quote | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Last: | $35.5157 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $35.5157 |
High: | $0 |
Low: | $0 |
Volume: | 12,600 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Publication of annual report for financial year 2023 Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board members Extraordinary Shareholders’ Meeting resolutions include approval of renewal of authorize...
Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive Non-Independent Director by way of cooptation. Andrew Dickinson is Gile...
Message Board Posts | Galapagos Genomics Ord (OTCMKTS:GLPGF)
Subject | By | Source | When |
---|---|---|---|
Galapagos Genomics NV changed to Galapagos NV: | Renee | investorshub | 10/02/2015 8:59:30 PM |
Galapagos acquires structure-based drug discovery from Sareum | surf1944 | investorshub | 09/05/2008 1:13:36 AM |
UCB transfers UK-based medicinal chemistry program to BioFocus DPI | surf1944 | investorshub | 08/18/2008 4:01:00 PM |
Galapagos announces milestone payment of EUR 0.8 million | surf1944 | investorshub | 07/10/2008 2:40:55 PM |
Galapagos signs research agreement with UCL | surf1944 | investorshub | 06/03/2008 1:08:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Galapagos Genomics Ord Company Name:
GLPGF Stock Symbol:
OTCMKTS Market:
Publication of annual report for financial year 2023 Annual Shareholders’ Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board members Extraordinary Shareholders’ Meeting resolutions include approval of renewal of authorize...
Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive Non-Independent Director by way of cooptation. Andrew Dickinson is Gile...
Full year 2023 key financials : Group net revenues of €783.5 million, including Jyseleca® net sales of €112.3 million Cash and current financial investments of €3.7 billion on 31 December 2023 Operational cash burn i of €...